Cargando…
Biomarkers and experimental models for cancer immunology investigation
The rapid advancement of tumor immunotherapies poses challenges for the tools used in cancer immunology research, highlighting the need for highly effective biomarkers and reproducible experimental models. Current immunotherapy biomarkers encompass surface protein markers such as PD‐L1, genetic feat...
Autores principales: | Xu, Hengyi, Jia, Ziqi, Liu, Fengshuo, Li, Jiayi, Huang, Yansong, Jiang, Yiwen, Pu, Pengming, Shang, Tongxuan, Tang, Pengrui, Zhou, Yongxin, Yang, Yufan, Su, Jianzhong, Liu, Jiaqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693314/ https://www.ncbi.nlm.nih.gov/pubmed/38045830 http://dx.doi.org/10.1002/mco2.437 |
Ejemplares similares
-
ANKRD29, as a new prognostic and immunological biomarker of non–small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway
por: Zhao, Hanqing, et al.
Publicado: (2023) -
Handbook of experimental immunology
Publicado: (1967) -
Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
por: Wang, Kai, et al.
Publicado: (2022) -
Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022) -
Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma
por: Qiao, Shaoyi, et al.
Publicado: (2022)